• NCOA6 knockdown sensitizes pancreatic cancer cells to RSL3-induced ferroptosis and gemcitabine.
• Mechanistically, NCOA6 knockdown upregulates ACSL4 and downregulates SCD1, altering lipid metabolism.
• Clinical specimens confirm the inverse correlation between NCOA6 and ACSL4/SCD1 expression.
• Targeting NCOA6 may overcome gemcitabine resistance in pancreatic cancer.
Download Full PDF: NCOA6 knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine | SinoBioData | SinoBioData